Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of serum cytokines and acute phase proteins as possible pharmacodynamic biomarkers to monitor endoscopic remission during ustekinumab therapy in patients with Crohn's disease.
Van den Berghe N, Alsoud D, Verstockt B, Vermeire S, Declerck P, Thomas D. Van den Berghe N, et al. Among authors: verstockt b. Therap Adv Gastroenterol. 2023 Aug 30;16:17562848231189110. doi: 10.1177/17562848231189110. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37655059 Free PMC article.
A Matrix-based Model Predicts Primary Response to Infliximab in Crohn's Disease.
Billiet T, Papamichael K, de Bruyn M, Verstockt B, Cleynen I, Princen F, Singh S, Ferrante M, Van Assche G, Vermeire S. Billiet T, et al. Among authors: verstockt b. J Crohns Colitis. 2015 Dec;9(12):1120-6. doi: 10.1093/ecco-jcc/jjv156. Epub 2015 Sep 7. J Crohns Colitis. 2015. PMID: 26351386
New treatment options for inflammatory bowel diseases.
Verstockt B, Ferrante M, Vermeire S, Van Assche G. Verstockt B, et al. J Gastroenterol. 2018 May;53(5):585-590. doi: 10.1007/s00535-018-1449-z. Epub 2018 Mar 19. J Gastroenterol. 2018. PMID: 29556726 Free PMC article. Review.
176 results